Form 4 for BSX Boston Scientific
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001225208-25-002992 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $37.50 | +5,949 | 8,063 | +281% | +$223.1K |
| DM | 2025-03-05 | 2025-03-03+ | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | S - Sale+OE | $104.95 | -7,631 | 432 | -95% | -$800.9K |
| D | 2025-03-05 | 2025-03-03 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | -5,949 | 2,383 | -71% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | M | A | 5,949 | $37.50 | 8,063 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-03 | S | D | 7,149 | $104.97 | 914 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.85 to $105.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-03-04 | S | D | 482 | $104.63 | 432 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-03-03 | M | D | 5,949 | $0.00 | 2,383 | D | $37.50 · — to 2031-02-17 | 5,949 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. |